CHBOF (China Health Technology Group Holding Co) Loans Receivable: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHBOF China Health Technology Group Holding Co Ltd CHBOF
25 GF Score
Price $0.03
GF Value $0.05
! 7 Warning Signs
View Full Analysis

What is China Health Technology Group Holding Co Loans Receivable?

China Health Technology Group Holding Co CHBOF 25 Loans Receivable is $0.00 Mil as of Dec. 2025. GuruFocus rates CHBOF with a GF Score™ of 25/100 and a GF Value™ of $0.05. The stock has 7 warning signs investors should review.

China Health Technology Group Holding Co's Loans Receivable for the quarter that ended in Dec. 2025 was $0.00 Mil.

China Health Technology Group Holding Co Loans Receivable Related Terms

China Health Technology Group Holding Co Loans Receivable Historical Data

* Premium members only.

The historical data trend for China Health Technology Group Holding Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Technology Group Holding Co Loans Receivable Chart

China Health Technology Group Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Jun22 Jun23 Jun24 Jun25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

China Health Technology Group Holding Co Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHBOF
25GF Score
China Health Technology Group Holding Co Ltd CHBOF
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Health Technology Group Holding Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of $0.00 Mil mean?
China Health Technology Group Holding Co (CHBOF) has a Loans Receivable of $0.00 Mil as of Dec. 2025. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on China Health Technology Group Holding Co and its competitors.
Is China Health Technology Group Holding Co's Loans Receivable too high?
China Health Technology Group Holding Co's current Loans Receivable is $0.00 Mil. Overall, China Health Technology Group Holding Co has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's Loans Receivable compare to SSD and UFPI?
China Health Technology Group Holding Co's Loans Receivable of $0.00 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Forest Products company?
A good Loans Receivable depends on the Forest Products industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on China Health Technology Group Holding Co and its competitors. China Health Technology Group Holding Co's current Loans Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current Loans Receivable of $0.00 Mil. The stock's GF Value™ is $0.05, compared to a current price of $0.03 — trading 34.1% below its estimated fair value. The current Loans Receivable is $0.00 Mil. China Health Technology Group Holding Co's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current Loans Receivable is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?

Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued. The current stock price of $0.03 is trading 34.1% below its estimated GF Value™ of $0.05.

Key valuation signals for CHBOF:

  • Loans Receivable: $0.00 Mil
  • GF Value™: $0.05 vs. price of $0.03 (34.1% below fair value)
  • GF Score™: 25/100 with 7 warning signs

No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Health Technology Group Holding Co Business Description

Other Exchanges 01069:Hong Kong
Address South Binhe Avenue, Room 4903, Building A, West Tower, C Future City, Futian District, Shenzhen, CHN
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
25GF Score

Get the complete analysis for CHBOF

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price
$0.05
GF Value